SincPD: An Explainable Method based on Sinc Filters to Diagnose Parkinson's Disease Severity by Gait Cycle Analysis

Introduction to the show: ident: AI Radio. Generated commentary on the latest Artificial Intelligence papers.

Tom: Next we'll be talking about the paper "SincPD: An Explainable Method based on Sinc Filters to Diagnose Parkinson's Disease Severity by Gait Cycle Analysis".

Jane: The paper was written by Armin Salimi-Badr, Mahan Veisi and Sadra Berangi from Shahid Beheshti University.

Tom: Stay tuned as we take you through the paper and discuss its implications.

Title and Authors: Tom: Welcome back to the show, everyone! We've got a fascinating paper on the table today, and I have to say, the title alone got me hooked. It's called "SincPD: An Explainable Method based on Sinc Filters to Diagnose Parkinson's Disease Severity by Gait Cycle Analysis." Jane, what do you make of that name?

Jane: Tom, I love it because it tells you exactly what's inside. SincPD—Sinc for those special filters they use, and PD for Parkinson's Disease. And the authors, Armin Salimi-Badr, Mahan Veisi, and Sadra Berangi from Shahid Beheshti University in Tehran, they're tackling something really important here. They're not just building a black box that says "yes" or "no" to Parkinson's; they're building one that can explain *why* it made that call.

Tom: And that's the part that gets me excited. We hear so much about deep learning being this mysterious thing where you feed in data and get an answer, but nobody can tell you how it got there. This paper is saying, "Hold on, we can actually peek inside and see what the model is looking at."

Jane: Exactly. They're using these things called Sinc filters, which are basically mathematical bandpass filters. Think of them like a radio tuner that only lets certain frequencies through. The model learns which frequencies in your walking pattern matter most for spotting Parkinson's. And because each filter has just two parameters—the center frequency and the bandwidth—you can literally look at them and say, "Oh, this filter is picking up signals between zero point four and zero point six Hertz."

Tom: So instead of thousands of abstract features, you get a handful of interpretable ones. That's a game-changer for clinical trust, right?

Jane: Absolutely. A doctor doesn't want to hear "the neural network says so." They want to hear "the model found that the frequency of your heel strikes is different from a healthy person's." That's something they can verify and understand.

Tom: And they're doing this with wearable sensors in people's shoes, measuring vertical ground reaction force. So it's not an MRI machine or a lab setup; it's something that could potentially be used in a regular clinic or even at home. That's a huge practical implication.

Jane: It is. And the fact that they're also trying to determine the *severity* of the disease, not just whether you have it, makes this even more valuable for tracking progression over time.

Tom: I'm already curious about how they actually built this thing. Let's dig into the method in the next segment.

Summary of the Paper: Tom: So, Jane, we've got this model that uses Sinc filters to look at gait data. But how does it actually work end to end? Walk me through the summary.

Jane: Okay, so they start with raw data from sixteen sensors under the feet, recording vertical ground reaction force. First step is preprocessing—they chop the signals into ten-second chunks, clean out bad data, and standardize everything. Then they do something clever: they take the difference between the left and right sensors, cutting the data down from sixteen channels to eight without losing the important stuff.

Tom: That's smart. It's like comparing the two feet directly instead of looking at each one in isolation.

Jane: Exactly. Then they build a deep learning model where the first layers are these SincConv1D layers—eight of them, one for each sensor. Each layer starts with one hundred filters, so that's eight hundred filters total. After those, they stack a couple of regular convolutional layers, then some dense layers, and finally a single output that says "patient" or "healthy."

Tom: And that initial model gets trained for a thousand epochs, hitting about ninety-eight point seven seven percent accuracy. Pretty solid. But here's the kicker—they don't stop there. They want to make it smaller and more explainable.

Jane: Right, and that's where the pruning comes in. They take all those learned filters and cluster them based on their cutoff frequencies using K-means. The idea is that many filters are redundant—they're picking up almost the same frequency bands. So they group them and keep just the medoid of each cluster as a representative.

Tom: So they went from eight hundred filters down to about thirty? That's a massive reduction.

Jane: It is, and the accuracy only drops a tiny bit—from ninety-eight point seven seven percent to ninety-eight point one five percent. That's a negligible loss for a model that's now way simpler and way easier to interpret.

Tom: And then they retrain the pruned model for a few epochs to fine-tune it. But the real magic happens when they start analyzing which filters and which sensors matter most. They use DBSCAN clustering to find representative signals for patients and healthy people, then pass those through the pruned filters and compare the energy outputs.

Tom: So they're literally measuring how much signal each filter lets through for each group, and the filters with the biggest difference are the ones doing the heavy lifting.

Jane: Precisely. And what they found is that sensors at the front of the foot—like the ball of the foot—and the back—like the heel—show the biggest energy differences. And the top filters are mostly picking up frequencies around zero point four to zero point six Hertz. That's a really specific finding that could have biomechanical meaning.

Tom: I love that they're not just saying "trust us, it works." They're saying "here's exactly what the model is paying attention to, and it makes sense given what we know about how Parkinson's affects gait."

Jane: And that's the whole point of explainable AI in medicine. It's not enough to be accurate; you have to be trustworthy.

Tom: Okay, so we've got the method. But what about the severity part? How do they go from "you have Parkinson's" to "you're at stage two point five"?

Improvements Suggested by the Paper: Tom: So Jane, the paper doesn't stop at just diagnosing Parkinson's. They also tackle severity. How does that work?

Jane: They use transfer learning. They take the pruned model we just talked about—the one that already knows how to extract meaningful features from gait data—and they freeze those layers. Then they add a new output layer that classifies into severity stages based on the modified Hoehn and Yahr scale.

Tom: So it's like taking a trained ear for music and teaching it to distinguish between different genres instead of just "music" and "not music."

Jane: That's a great analogy. And it works remarkably well—they hit ninety-seven point two two percent accuracy on the multi-class severity problem. That's better than several state-of-the-art methods they compared against, like a 1D CNN that got eighty-five point two three percent and an LSTM that got ninety-six point six percent.

Tom: And they're doing this with far fewer parameters. The pruned model has 872K parameters, while some of the other methods have tens of millions. That's a massive efficiency win.

Jane: It is, and it matters for real-world deployment. Smaller models run faster, use less memory, and can be deployed on edge devices like smartphones or wearable sensors themselves.

Tom: But the improvement I find most exciting is the explainability angle. They're not just saying "stage three"; they're showing which sensors and frequency bands drove that decision. For a clinician, that's gold.

Jane: Exactly. And they go one step further—they identify the top twenty percent of filters based on energy difference between patients and healthy subjects. The top filters are mostly from Sensor seven which is the ball of the foot, and Sensor two which is the heel. And they're all picking up frequencies in that zero point four to zero point six Hertz range.

Tom: That's such a concrete finding. It suggests that Parkinson's specifically affects the timing and force distribution of heel strikes and toe-offs, which makes total sense given what we know about the disease.

Jane: And that's the kind of insight that could feed back into clinical practice. Maybe doctors start paying more attention to those specific frequency bands when assessing patients, or maybe it informs the design of better wearable sensors.

Tom: I also like that they're using clustering to prune, which is a pretty general technique. You could apply this same approach to other medical signals—heart data, breathing patterns, even speech.

Jane: Absolutely. The methodology is not Parkinson's-specific. It's a template for building interpretable deep learning models on any time-series data.

Tom: So what's the catch? What are the limitations?

Jane: Well, the dataset is from PhysioNet, which is a public dataset with one hundred sixty-six subjects—ninety-three with Parkinson's and seventy-three healthy. It's a decent size, but it's not huge. And the severity stages only go up to stage three in their data, so they're not covering the most severe cases. Also, the data was collected in a lab setting with people walking at their own pace, which is good, but real-world conditions might be messier.

Tom: Still, for a proof of concept, this is really compelling. Let's wrap this up in the conclusion.

Conclusion: Tom: Alright, let's bring it home. We've been talking about "SincPD: An Explainable Method based on Sinc Filters to Diagnose Parkinson's Disease Severity by Gait Cycle Analysis," and honestly, this is one of those papers that makes me feel like we're finally moving toward AI we can actually trust in medicine.

Jane: I completely agree, Tom. The key takeaways are: they built a model that diagnoses Parkinson's with ninety-eight point seven seven percent accuracy, pruned it down to a fraction of its original size with almost no performance loss, and then extended it to classify severity with ninety-seven point two two percent accuracy. But the real win is that they can show you *which* sensors and *which* frequency bands are driving those decisions.

Tom: And those findings—that the heel and ball of the foot sensors matter most, and that the key frequencies are around zero point four to zero point six Hertz—those are things a clinician can actually use. They're not abstract neural network features; they're measurable, physical phenomena.

Jane: Right. And that's what makes this paper stand out. It's not just another deep learning model that beats the benchmark. It's a model that opens the black box and says, "Here's what I'm looking at, and here's why it makes sense."

Tom: The implications go beyond Parkinson's, too. The pruning method and the explainability framework could be applied to any time-series medical data. That's a big deal.

Jane: It is. And while there are limitations—the dataset size, the limited severity range—this is a strong foundation. Future work could validate on larger, more diverse populations and maybe even test in real-world clinical settings.

Tom: Well said. We're going to say goodbye to SincPD and get ready to look at the next paper on the arXiv. Thanks for tuning in, everyone. We'll see you next time.

Jane: Take care, and keep listening!